Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

FDA greenlights clinical trials testing novel MRI contrast agent for prostate cancer

Case Western Reserve University developed the gadolinium material, which is expected to be tested in 30 healthy participants beginning later this month.

Thumbnail

Nuclear medicine groups announce new registry to bolster prostate cancer imaging with SPECT

The Nobody Left Behind or NOBLE Registry aims to establish prostate-specific membrane antigen SPECT imaging as a cost-effective and widely available alternative to PSMA-PET.

Thumbnail

FDA warns providers after 2 patients die from ultrasound contrast-agent reactions

The administration is urging clinicians to ask patients about polyethylene glycol allergies and keep resuscitation personnel on hand during exams, according to a recently issued alert. 

Thumbnail

AI uses ECG, X-ray data to improve treatment of arrhythmic disorders

An international group of researchers developed a deep learning model capable of identifying accessory pathways in patients with Wolff-Parkinson-White syndrome.

New low-cost ultrasound training tool helps clinicians deliver common joint treatment

The 3D-printed model helps physicians practice administering imaging-guided corticosteroid finger injections, researchers reported in EMJ Radiology.

M&A mergers and acquisitions business deal

Medical imaging isotope producer Shine finalizes merger with fusion technology specialist

With the help of Phoenix's advanced industrial imaging capabilities, the new entity hopes to ramp up its production of molybdenum-99.

Thumbnail

Standardized tumor reporting may ensure busy radiologists are front and center during cancer care

Consistent metrics would limit frustrating back-and-forths between rads and providers while also significantly enhancing patient care.

Thumbnail

Two new molecular imaging and therapy trials are underway

Hoag Family Cancer Institute in California is testing a radiotracer for myeloma and PSMA therapy in patients with high-risk prostate cancer.